TABLE 3.
BMI %Δ Group |
Unadjusted | Base Model* |
Base Model + Y0 BMI |
Base Model + Y25 BMI |
||||
---|---|---|---|---|---|---|---|---|
N=2615 | N=2615 | N=2615 | N=2611 | |||||
OR (95% CI) |
P value | OR (95% CI) |
P value | OR (95% CI) |
P value | OR (95% CI) |
P value | |
Stable | Reference | |||||||
Moderate Increase | 2.65 (1.71–4.09) | 0.005 | 3.35 (2.07–5.43) | 0.04 | 4.40 (2.66–7.31) | 0.03 | 2.56 (1.55–4.21) | 0.69 |
High Increase | 4.27 (2.71–6.73) | 0.0002 | 7.80 (4.60–13.23) | <0.0001 | 11.38 (6.51–19.89) | <0.0001 | 3.73 (2.13–6.52) | 0.001 |
Extreme Increase | 5.51 (3.22–9.42) | <0.0001 | 12.68 (6.68–24.09) | <0.0001 | 21.18 (10.75–41.72) | <0.0001 | 3.68 (1.83–7.41) | 0.04 |
Results presented as Odds Ratio (95% Confidence Interval)
NAFLD = liver attenuation ≤ 40 HU after exclusion for secondary causes of liver fat
Base model adjusted for baseline age, sex, race, education, center, cumulative systolic blood pressure (mm Hg-years), number of years with blood pressure medications, cumulative triglycerides (mg/dl-years), cumulative years with diabetes, cumulative alcohol use (drinks/day), physical activity level (exercise units-year) and pack-years of cigarette smoking exposure
Abbreviations: BMI, body mass index; NAFLD, nonalcoholic fatty liver disease; OR, odds ratio; CI, confidence interval